Arcutis Biotherapeutics, Inc.
ARQT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787306
In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Arcutis Biotherapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 241
- +35 vs. Q4 2024
- Shares held
- 125.7M
- −2.78M (−2.2%) vs. Q4 2024
- Total value
- $1.97B
- +$176.0M (+9.8%) vs. Q4 2024
- New holders
- 64
- 66 more added
- Sold out
- 29
- 81 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARQT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 272 | $3.45B |
| Q1 2026 | 270 | $3.12B |
| Q4 2025 | 283 | $3.75B |
| Q3 2025 | 239 | $2.37B |
| Q2 2025 | 230 | $1.78B |
| Q1 2025 | 241 | $1.97B |
| Q4 2024 | 208 | $1.79B |
| Q3 2024 | 188 | $1.20B |
| Q2 2024 | 186 | $1.18B |
| Q1 2024 | 168 | $1.24B |
| Q4 2023 | 133 | $327.1M |
| Q3 2023 | 134 | $356.7M |
| Q2 2023 | 136 | $684.0M |
| Q1 2023 | 144 | $787.6M |
| Q4 2022 | 141 | $979.6M |
| Q3 2022 | 139 | $1.13B |
| Q2 2022 | 115 | $1.05B |
| Q1 2022 | 106 | $929.8M |
| Q4 2021 | 93 | $961.8M |
| Q3 2021 | 103 | $1.09B |
| Q2 2021 | 102 | $1.24B |
| Q1 2021 | 94 | $1.35B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Arcutis Biotherapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| StemPoint Capital LP | 440,073 | $6.88M | 2.20% | −60,893−12.2% | Reduced |
| First Trust Advisors LP | 440,185 | $6.88M | 0.01% | +177,048+67.3% | Added |
| Millennium Management LLC | 473,625 | $7.41M | 0.01% | −1,836,538−79.5% | Reduced |
| Bank of America Corp | 514,951 | $8.05M | 0.00% | −21,507−4.0% | Reduced |
| Fishman Jay A Ltd | 533,150 | $8.34M | 0.91% | −3,250−0.6% | Reduced |
| JPMorgan Chase & Co | 543,382 | $8.50M | 0.00% | −598,123−52.4% | Reduced |
| Standard Life Aberdeen plc | 587,540 | $9.19M | 0.02% | +105,466+21.9% | Added |
| Prudential Financial Inc | 593,195 | $9.28M | 0.01% | +630+0.1% | Added |
| Simplify Asset Management Inc. | 660,557 | $10.3M | 0.48% | −81,742−11.0% | Reduced |
| Norges Bank | 679,320 | $10.6M | 0.00% | +146,527+27.5% | Added |
| Federated Hermes, Inc. | 737,555 | $11.5M | 0.02% | +244,633+49.6% | Added |
| Nuveen, LLC | 815,816 | $12.8M | 0.00% | +815,816 | New |
| Point72 Asset Management, L.P. | 830,478 | $13.0M | 0.04% | −923,044−52.6% | Reduced |
| Tejara Capital Ltd | 846,221 | $13.2M | 6.52% | −40,617−4.6% | Reduced |
| Charles Schwab Investment Management Inc | 860,768 | $13.5M | 0.00% | −18,036−2.1% | Reduced |
| Cercano Management LLC | 928,701 | $14.5M | 0.43% | −326,664−26.0% | Reduced |
| Northern Trust Corp | 976,070 | $15.3M | 0.00% | −14,986−1.5% | Reduced |
| Candriam Luxembourg S.C.A. | 1,035,576 | $16.2M | 0.10% | −6,568−0.6% | Reduced |
| Driehaus Capital Management LLC | 1,092,735 | $17.1M | 0.16% | −4,034−0.4% | Reduced |
| Goldman Sachs Group Inc | 1,103,413 | $17.3M | 0.00% | −202,754−15.5% | Reduced |
| Invesco Ltd. | 1,328,954 | $20.8M | 0.00% | +202,286+18.0% | Added |
| Cormorant Asset Management, LP | 1,350,000 | $21.1M | 1.60% | −475,000−26.0% | Reduced |
| Paradigm Biocapital Advisors LP | 1,465,334 | $22.9M | 1.05% | +1,465,334 | New |
| GW&K Investment Management, LLC | 1,512,211 | $23.7M | 0.22% | −31,873−2.1% | Reduced |
| American Century Companies Inc | 1,652,492 | $25.8M | 0.02% | +21,266+1.3% | Added |
| Ensign Peak Advisors, Inc | 1,988,389 | $31.1M | 0.06% | −385,751−16.2% | Reduced |
| D. E. Shaw & Co., Inc. | 1,989,508 | $31.1M | 0.04% | −524,069−20.8% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 2,120,508 | $33.2M | 26.84% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 2,546,947 | $39.8M | 0.00% | +74,217+3.0% | Added |
| Franklin Resources Inc | 2,761,767 | $43.2M | 0.01% | −547,552−16.5% | Reduced |
| UBS Group AG | 2,920,008 | $45.7M | 0.01% | +130,478+4.7% | Added |
| Morgan Stanley | 3,838,541 | $60.0M | 0.00% | −405,370−9.6% | Reduced |
| Gilder Gagnon Howe & Co LLC | 4,096,051 | $64.1M | 0.84% | +193,060+4.9% | Added |
| State Street Corp | 4,474,203 | $70.0M | 0.00% | −476,522−9.6% | Reduced |
| Polar Capital Holdings Plc | 6,706,475 | $104.9M | 0.65% | −670,906−9.1% | Reduced |
| Vanguard Group Inc | 6,818,078 | $106.6M | 0.00% | +377,363+5.9% | Added |
| Frazier Life Sciences Management, L.P. | 8,785,284 | $137.4M | 6.28% | 00.0% | Unchanged |
| BlackRock, Inc. | 8,892,337 | $139.1M | 0.00% | −256,221−2.8% | Reduced |
| Rubric Capital Management LP | 10,966,672 | $171.5M | 3.07% | 00.0% | Unchanged |
| Jennison Associates LLC | 11,360,875 | $177.7M | 0.12% | −978,917−7.9% | Reduced |
| Suvretta Capital Management, LLC | 11,422,978 | $178.7M | 7.23% | +23,840+0.2% | Added |
| Eversept Partners, LP | 0 | $0 | 0.00% | −191,158−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −128,248−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Mangrove Partners | 0 | $0 | 0.00% | −59,066−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −57,658−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −50,039−100.0% | Sold out |
| Zweig-DiMenna Associates LLC | 0 | $0 | 0.00% | −41,500−100.0% | Sold out |
| Freestone Grove Partners LP | 0 | $0 | 0.00% | −35,818−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −32,601−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −23,145−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −22,810−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −20,912−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −20,023−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −17,603−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −17,587−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −15,933−100.0% | Sold out |
| Altfest L J & Co Inc | 0 | $0 | 0.00% | −14,455−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −13,686−100.0% | Sold out |
| Tradewinds, LLC. | 0 | $0 | 0.00% | −14,035−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −11,216−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −10,028−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −5,338−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −3,300−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −1,626−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Johnson Financial Group, Inc. | 0 | $0 | 0.00% | −199−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −148−100.0% | Sold out |
| First United Bank Trust | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Legacy Investment Solutions, LLC | – | – | – | – | Not filed |